Evoke Pharma Statistics Share Statistics Evoke Pharma has 1.49M
shares outstanding. The number of shares has increased by 82.22%
in one year.
Shares Outstanding 1.49M Shares Change (YoY) 82.22% Shares Change (QoQ) 0% Owned by Institutions (%) 6.09% Shares Floating 1.41M Failed to Deliver (FTD) Shares 71,922 FTD / Avg. Volume 3.03%
Short Selling Information The latest short interest is 241.72K, so 16.19% of the outstanding
shares have been sold short.
Short Interest 241.72K Short % of Shares Out 16.19% Short % of Float 18.21% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.57 and the forward
PE ratio is 3.7.
Evoke Pharma's PEG ratio is
0.02.
PE Ratio -1.57 Forward PE 3.7 PS Ratio 0.82 Forward PS 0.3 PB Ratio 0 P/FCF Ratio -1.54 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Evoke Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.66,
with a Debt / Equity ratio of 0.
Current Ratio 1.66 Quick Ratio 1.62 Debt / Equity 0 Debt / EBITDA -1.06 Debt / FCF -0.95 Interest Coverage -10.38
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $3.42M Profits Per Employee $-1.78M Employee Count 3 Asset Turnover 0.59 Inventory Turnover 0.8
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -4.22% in the
last 52 weeks. The beta is -0.04, so Evoke Pharma's
price volatility has been lower than the market average.
Beta -0.04 52-Week Price Change -4.22% 50-Day Moving Average 3.88 200-Day Moving Average 4.03 Relative Strength Index (RSI) 60.97 Average Volume (20 Days) 2,372,129
Income Statement In the last 12 months, Evoke Pharma had revenue of 10.25M
and earned -5.35M
in profits. Earnings per share was -2.81.
Revenue 10.25M Gross Profit 9.89M Operating Income -5.2M Net Income -5.35M EBITDA -4.85M EBIT -4.85M Earnings Per Share (EPS) -2.81
Full Income Statement Balance Sheet The company has 13.6M in cash and 5.16M in
debt, giving a net cash position of 8.44M.
Cash & Cash Equivalents 13.6M Total Debt 5.16M Net Cash 8.44M Retained Earnings -128.79M Total Assets 16.38M Working Capital 5.78M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.46M
and capital expenditures 0, giving a free cash flow of -5.46M.
Operating Cash Flow -5.46M Capital Expenditures n/a Free Cash Flow -5.46M FCF Per Share -2.87
Full Cash Flow Statement Margins Gross margin is 96.52%, with operating and profit margins of -50.77% and -52.22%.
Gross Margin 96.52% Operating Margin -50.77% Pretax Margin -52.22% Profit Margin -52.22% EBITDA Margin -47.33% EBIT Margin -50.77% FCF Margin -53.26%
Dividends & Yields EVOK does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for EVOK.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 1, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Aug 1, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -10.46 Piotroski F-Score 4
